2 MATERIAL AND METHODS
This prospective, single-center, randomized trial was registered with
the Chinese Clinical Trial Registry
as ChiCTR 2000031338 and conducted
at Beijng Anzhen Hospital. All patients provided written informed
consent. The trial was conducted in compliance with the International
Conference on Harmonisation and the Declaration of Helsinki. This study
was approved by the Beijing Anzhen Hospital Medical Ethics Committee.